The genomic and epigenomic abnormalities of plasma cfDNA as liquid biopsy biomarkers to detect hepatocellular carcinoma: a multicenter cohort study
De‐Zhen Guo(Sun Yat-sen University), Jian Zhou(Nanjing University), Ruijingfang Jiang, Xuxiao Chen(Ruijin Hospital), 陈慧豪(BGI Group (China)), Jiaxi Peng(Dalian Institute of Chemical Physics), Fengming Zhang(BGI Group (China)), Xuxiao Chen(BGI Group (China)), Yongjun Chen(Nantong University), Yupeng Wang(University of Pittsburgh), Yupeng Wang(Guangdong University of Technology), Shiyu Zhang(Hainan Medical University), Jianlong Sun(ShanghaiTech University), Xin-Rong Yang(BGI Group (China)), Ao Huang(Ministry of Education), Yuying Wang(BGI Group (China)), Jiefei Wang(Shanghai Public Health Clinical Center), Jie Yuan(Guangzhou University of Chinese Medicine), Jia Fan(BGI Group (China)), Shida Zhu(BGI Group (China)), Hongying Guo(Nantong University), Jianwen Cheng(Fudan University)
Cited by 11
Related Papers
Clonal dynamics of native haematopoiesis
|Nature|2014|838
Clonal analysis of lineage fate in native haematopoiesis
|Nature|2018|597
Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma
|Cell Research|2020|483
Genomic basis for RNA alterations in cancer
|Nature|2020|426
A genetic screen identifies an LKB1–MARK signalling axis controlling the Hippo–YAP pathway
|Nature Cell Biology|2013|296